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Abstract
Background Long-term studies on the evolution of serum bio-
chemical indicators in anorexia nervosa (AN) patients during treat-
ment are lacking in the literature. Thus, a 1-year follow-up of serum
biochemical parameters in a homogeneous group of AN patients was
performed.
Methods Fourteen restricting-type AN patients were studied on
admission to hospital, after 1 month of inpatient treatment and after
6 and 12 months after admission.
Results Red blood cell count (RBC) and haemoglobin, serum
glucose, total protein and the enzyme activities aspartate amino-
transferase (AST), alkaline phosphatase (AlP), lactate dehydrogenase
(LDH) and creatine kinase (CK) were significantly lower in patients
on admission than in the control group. Total protein, high-density
lipoprotein cholesterol (HDL-c), AST, AlP and CK showed significant
changes among time points (A N O V A, P < 0.05). Significant
correlations were found between the change in RBC, haemoglobin,
haematocrit, and the change in weight and body mass index
(r = 0.74–0.86; P < 0.01). High cholesterol and amylase activity were
found at all time points. While AST, LDH and CK reached control
values within 6 months of treatment, AlP was always lower.
Conclusion Serum AlP, hypercholesterolaemia and RBC seem to
need longer periods of treatment with further weight gain to fully
normalize. Therefore, these parameters should be monitored in AN
patients long-term follow-up.
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Introduction
The malnourished condition of patients with an-
orexia nervosa (AN) affects all organs and systems
in the body. The extent of the metabolic changes
depends on the duration and severity of the re-
duced food intake and the amount of weight lost.
Serum biochemical markers of nutritional status
and metabolism are routinely examined in AN
patients after diagnosis; however, most markers
are usually normal. This has led to the conclusion
that adaptive mechanisms preserve their nutri-
tional status until advanced stages of debilitation
(Lucas, 1977). This might be the reason why only a
few papers have been published containing values
for these routine biochemical parameters in AN
patients. However, some of these studies have
been carried out in groups that showed poor
homogeneity and included subjects who could
have belonged to different subtypes or even to
different categories of eating disorders (Pryor
et al., 1996). This is of importance since studies in
AN patients have shown that the nutritional status
in these patients varies according to factors such
as the duration of the illness prior to treatment or
the different types of compensatory behaviours
adopted to control weight (Marcos, 1997). More-
over, the studies published are mainly of two
types; cross-sectional studies (Pertschuk et al.,
1982; Dowd et al., 1983; Mira et al., 1987, 1989;
Van Binsbergen et al., 1988; Varela et al., 1992) or
studies comparing a group of AN patients before
and after nutritional rehabilitation (Wyatt et al.,
1982; Barbe et al., 1993; Megia et al., 1994; Fink
et al., 1996; Smith et al., 1996). There are no
studies in the literature measuring biochemical
markers in AN patients in long-term follow-up.
On this basis, the authors have evaluated some
serum biochemical parameters in a follow-up
study of a homogenous group of AN patients
diagnosed with the restricting-type of the illness,
and receiving the same multidisciplinary treat-
ment. The aim of the study was to measure these
parameters at different time points during in-
hospital and outpatient periods of treatment in a
1-year follow-up.
Methods
Subjects and study design
A group of 14 adolescent AN patients recruited
on admission to the Hospital de Mo´stoles (Ma-
drid, Spain) was included in this 1-year follow-
up study. All the patients met criteria for the
diagnosis of AN. To increase the homogeneity of
the study group only female patients in the
adolescent age (12–18 years), undergoing their
first hospital admission and with restricting type
AN (DSM IV) (American Psychiatric Association,
1994) were included. The follow-up covered
inpatient and outpatient periods of treatment for
the 14 patients, and thus, four different time
points were considered: (i) when AN patients
had been recently admitted to a rehabilitation
programme in the hospital (t0); (ii) 1 month la-
ter (t1); (iii) 6 months after admission (t6); and
(iv) 12 months after admission (t12). In all, 26
patients were first recruited for the study but 12
were considered drop outs after failing to com-
ply with any of the dates (time points) in the
study. The results obtained are limited to those
14 patients. At t0, the mean duration of the ill-
ness was relatively short (9.4 ± 6.3 months).
No differences were observed in age, weight, or
duration of the illness at admission between
those patients who did not finish the study and
those who did. At t0 and t1, all patients were in
hospital, where as at t6 and t12, there were 12
and 13 outpatients and two and one inpatients
respectively. In the course of the year, six out of
the 14 patients were readmitted; four of them on
one occasion and two patients had up to two
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more admissions in the year. Fifteen healthy
subjects matched by age, sex and sociocultural
background were recruited from a school and
were used as a control group. All subjects gave
their full and informed consent once the purpose
and nature of the study had been explained.
Parental consent was also obtained for those
under 18 years of age. The study was conducted
in accordance with the ethical rules of the Hel-
sinki Declaration as revised in 1983 and the EEC
Good Clinical Practice guidelines (document 111/
3976/88 of July 1990) and the study protocol was
approved by the Ethics Committee of the Hos-
pital de Mostoles.
Treatment protocol
According to the Hospital of Mostoles’ refeeding
program for AN patients, energy intake varied
between 2090 and 4180 kJ day)1 (500–1000 kcal -
day)1) for the first 2–4 days of the hospital
admission, and was increased by 2090 kJ
(500 kcal) every 3–4 days to ensure an acceptable
weight gain of 0.5–1.5 kg week)1 at the beginning
of the treatment and 200–400 g week)1 thereafter.
During the weight gain period, four solid meals
plus two liquid supplements, if necessary, were
offered to the patient. Dietary management was
supported by psychological therapy to correct
eating behaviour. As inpatients, some patients
were allowed to do rehabilitation exercises in a
fitness room for half an hour a day. On admission,
an eventual discharge weight was established by
the treating physician, which was within one SD
(standard deviation) of the ideal body weight
(IBW) for age and height. When patients entered
outpatient treatment, a normocaloric diet was
prescribed together with outpatient psychological
therapy.
Measures and biochemical analyses
At every time point of the study, basic anthropo-
metric data were obtained by the standard pro-
cedure after an overnight fast. Weight and height
were determined without clothes and shoes, using
a digital electronic weighing scale (Seca alpha;
Igmy, France; range: 0.1–150 kg) and a digital
stadiometer (Harpender Pfifter 450; Carlstadt, NJ,
USA; range 0.70–2.05 m) respectively. From these
data, body mass index (BMI) [weight (kg)/height2
(m2)], Z-score of the BMI and IBW percentage (IBW
%) according to Spanish growth reference charts
(Herna´ndez et al., 1988) were calculated. Blood was
also collected in the early morning by puncture of
the cubital vein under fasting conditions. Two
millilitre was collected in EDTA-K3 tubes for hae-
matology analysis and 6–7 mL in gel-containing
tubes for serum separation. Red blood cell counts
(RBC), haemoglobin, haematocrit and corpuscular
indexes were analysed in an automatic cell counter
(Technicon-Bayer H1). The following biochemical
parameters were assessed in serum samples using a
Merck autoanalyser AU 510 (Merck, Hamburg,
Germany): glucose, total protein, urea, uric acid,
creatinine, total bilirrubin, lipid profile (total
cholesterol and lipoprotein-cholesterol fractions)
and the enzyme activities of aspartate amino-
transferase (AST), alanine aminotransferase (ALT),
gamma-glutamil transferase (c-GT), alkaline
phosphatase (AlP), lactate dehydrogenase (LDH),
creatine kinase (CK) and amylase.
Statistical analysis
All values reported are mean ± SD. Data were
analysed by repeated-measures A N O V A. When the
analysis indicated a significant effect of time
(P < 0.05), the Bonferroni method was used for a
pairwise comparison between the four time points
and for calculation of 95% confidence limits for
the differences between the time points. Values of
P < 0.05 were considered significant. The Bonfer-
roni method encompasses a downward adjustment
of significance limits for the differences between
the time points. All P-values were two-tailed. Dif-
ferences between the AN group and the control
group were assessed by Student’s t-test. Differ-
ences were considered statistically significant at
P < 0.05. The variables’ change between time
points was also calculated and the associations
between the biochemical and anthropometrical
parameters’ changes in time intervals were as-
sessed using Pearson’s correlation test. All the
tests were performed by the S P S S 11.0.1 (SPSS Inc.,
Chicago, IL, USA).
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Results
Anthropometrical parameters are presented in
Table 1. While height was similar in patients and
controls, weight and BMI were significantly lower
in all the stages in the AN group. Nevertheless, a
significant increase was observed in weight and
BMI at t1, both parameters remaining unmodified
thereafter. RBC and related parameters are shown
in Table 2. No significant changes were observed
in the red blood cells by repeated-measures A N O V A,
except for mean corpuscular haemoglobin (MCH),
which showed a significant increase in t12 com-
pared to t6. Eleven out of 14 patients showed MCH
values above the normal range in t12. Significantly
lower values compared to the control group were
found for RBC, haemoglobin and MCH concen-
tration (MCHC) in t0, while significantly higher
values were observed for mean corpuscular vol-
ume. A nonsignificant trend was observed towards
increasing values of RBC and haemoglobin during
the 1-year follow-up. In addition, the changes in
RBC, haemoglobin and haematocrit between t0
and t12 were positively correlated with the changes
in weight, IBW (%) and BMI in this time interval
(r between 0.74 and 0.86; P < 0.01).
Serum biochemical parameters are shown in
Table 3. Changes during the follow-up were ob-
served for total protein, HDL-c and the enzymes
AST, AlP and CK. Total protein, HDL-c and CK
increased significantly at t6 and t12 compared to
the inpatient period of treatment. AST also in-
creased along the follow-up reaching at t12 sig-
nificantly higher values than at t0 and t1, and AlP
increased significantly already during the inpatient
treatment (t1 versus t0) and was maintained
unmodified thereafter. All these parameters
showed lower values than the control group on
Table 1 Anthropometrical parameters in controls and patients with anorexia nervosa at different time points during a 1-year
follow-up
Controls t0 t1 t6 t12
Repeated-measures
A N O V A P-value
Age (years) 15.1 ± 1.4 15.1 ± 2.6 15.2 ± 2.6 15.6 ± 2.6 16.1 ± 2.6 < 0.001
Height (cm) 161.7 ± 5.4 160.6 ± 6.3 160.8 ± 6.1 160.9 ± 6.3 161.2 ± 6.5 0.206
Weight (kg) 53.0 ± 5.0 39.4 ± 6.1**,a,b,c 43.0 ± 4.9**,a 44.8 ± 4.5**,b 45.2 ± 6.7**,c < 0.001
BMI (kg m)2) 20.2 ± 1.3 15.2 ± 1.7**,a,b,c 16.6 ± 1.1**,a 17.3 ± 1.1**,b 17.3 ± 2.0**,c < 0.001
Score Z (BMI) )0.12 ± 0.48 )1.93 ± 0.78**,b,c )1.44 ± 0.53**,b )1.29 ± 0.61**,c )1.33 ± 0.96** 0.002
IBW (%) 94.6 ± 7.6 72.2 ± 7.9**,a,c,d 78.7 ± 6.0**,a 82.1 ± 7.2**,c 82.5 ± 10.0*,d < 0.001
Weight gain (kg) – – 3.6 ± 2.1 5.4 ± 3.7 5.8 ± 4.5 0.179
BMI, body mass index; IBW, ideal body weight.
Values are given as mean ± SD.
Significant differences against Controls (Student’s t-test, independent data): *P £ 0.01; **P £ 0.001.
Significant differences between mean values with common superscripts (Bonferroni test): a,bP £ 0.01; c,dP £ 0.001.
Table 2 Red blood cells (RBC) and haematological indices in controls and anorexia nervosa patients at different time points during
a 1-year follow-up
Controls t0 t1 t6 t12
Repeated-measures
A N O V A P-value
RBC (·1012 L)1) 4.9 ± 0.3 4.2 ± 0.4*** 4.0 ± 0.3*** 4.3 ± 0.3*** 4.3 ± 0.3*** 0.523
Haemoglobin (g dL)1) 14.8 ± 1.2 12.9 ± 1.5** 12.8 ± 1.0*** 13.2 ± 0.8*** 13.7 ± 1.2* 0.327
Haematocrit (%) 40.7 ± 3.3 38.6 ± 4.2 38.0 ± 3.3* 39.8 ± 3.0 40.6 ± 3.1 0.444
MCV (fl) 83.0 ± 3.8 92.9 ± 3.7*** 94.6 ± 38*** 93.6 ± 3.9*** 94.1 ± 2.9*** 0.185
MCH (pg) 30.1 ± 1.8 30.9 ± 1.4 32.0 ± 1.9* 30.9 ± 1.4a 31.8 ± 1.3**,a < 0.05
MCHC (g dL)1) 36.3 ± 1.2 33.6 ± 1.4*** 33.8 ± 1.53*** 33.1 ± 1.0*** 33.8 ± 0.8*** 0.165
MCV, mean corpuscular volume; MCH, mean corpuscular haemoglobin; MCHC, mean corpuscular haemoglobin concentration.
Values are given as mean ± SD.
Significant differences against controls (Student’s t-test, independent data): *P £ 0.05; **P £ 0.01; ***P £ 0.001.
Significant differences between mean values with common superscripts (Bonferroni test): aP £ 0.05.
E. Nova et al.26
 2007 The Authors. Journal compilation.
 2007 The British Dietetic Association Ltd 2008 J Hum Nutr Diet, 21, pp. 23–30
admission but reached control values at t6 and t12
except for AlP that was maintained below control
values throughout the study. Glucose and LDH
also showed values lower than the control group at
t0 but reached control values with refeeding. Urea,
total cholesterol, low-density lipoprotein choles-
terol (LDL-c) and amylase concentrations in ser-
um were higher than in the control group on
admission and at all subsequent time points.
A significant correlation was observed between
AlP activity and the Z-score of the BMI at t0, t1 and
t6 (r = 0.80, P < 0.001; r = 0.71, P < 0.01 and
r = 0.61, P < 0.05 respectively). In addition, a
negative correlation was found between the
change in AlP activity from t0 to t1 and the
increase in weight during the same period
(r = )0.86; P < 0,001).
Discussion
The results found in this group of restricting-type
adolescent AN patients showed that serum bio-
chemical parameters measured on hospital
admission are impaired in comparison with the
control group. Protein, glucose and most enzyme
activities are low in response to the restricted
nutrient intake, and return to normal either dur-
ing admission or during the outpatient period of
treatment. However, other parameters such as
RBC, AlP, cholesterol and amylase, which did not
Table 3 Serum biochemical parameters in controls and anorexia nervosa patients at different time points during a 1-year follow-
up
Controls t0 t1 t6 t12
Repeated-measures
A N O V A P-value
Glucose
(mg dL)1)
86.6 ± 4.5 77.4 ± 7.7*** 78.8 ± 17.2 83.8 ± 12.7 86.4 ± 8.4 0.252
Total protein
(g dL)1)
7.47 ± 0.27 6.98 ± 0.67*,a,b 6.96 ± 0.91 7.70 ± 0.52a 7.47 ± 0.30b <0.01
Urea
(mg dL)1)
23.8 ± 5.0 39.8 ± 10.7*** 37.9 ± 10.8*** 38.8 ± 9.7*** 38.6 ± 10.5*** 0.918
Uric acid
(mg dL)1)
4.2 ± 0.6 3.7 ± 0.9 3.7 ± 0.7* 3.8 ± 0.8 4.2 ± 1.1 0.578
Creatinine
(mg dL)1)
0.87 ± 0.09 0.89 ± 0.12 0.88 ± 0.13 0.99 ± 0.17* 0.96 ± 0.11* 0.111
Total bilirubin
(mg dL)1)
0.38 ± 0.26 0.38 ± 0.23 0.34 ± 0.22 0.35 ± 0.18 0.37 ± 0.17 0.835
TG (mg dL)1) 71.5 ± 33.1 69.4 ± 30.2 58.7 ± 31.2 64.6 ± 24.0 64.7 ± 20.3 0.185
CHOL
(mg dL)1)
163.9 ± 27.8 208.2 ± 61.8* 208.0 ± 49.2** 225.7 ± 63.6** 208.4 ± 41.2** 0.363
HDL-c
(mg dL)1)
59.5 ± 7.3 45.1 ± 18.3**,c 46.9 ± 11.9**,d,e 52.6 ± 13.4d 61.6 ± 18.0c,e <0.01
LDL-c
(mg dL)1)
90.0 ± 23.7 154.5 ± 65.2 149.4 ± 50.6*** 162.4 ± 67.6 133.8 ± 54.6** 0.455
VLDL-c
(mg dL)1)
14.3 ± 6.6 13.9 ± 6.0 11.7 ± 6.2 12.9 ± 4.8 12.9 ± 4.1 0.185
AST (U L)1) 16.0 ± 2.2 11.4 ± 4.4**,f 12.4 ± 2.6***,g 15.2 ± 3.6 17.9 ± 5.1f,g <0.01
ALT (U L)1) 11.3 ± 2.3 10.6 ± 4.4 10.1 ± 3.2 10.3 ± 2.9 12.6 ± 5.4 0.578
c-GT (U L)1) 10.0 ± 2.0 11.4 ± 4.1 11.9 ± 3.9 13.1 ± 6.6 13.0 ± 5.0 0.846
AlP (U L)1) 325.0 ± 164.8 119.4 ± 37.4***,h,i,j 164.5 ± 68.7**,h 190.3 ± 97.6*,i 192.1 ± 117.1*,j <0.01
LDH (U L)1) 312.8 ± 53.4 248.9 ± 84.1* 269.0 ± 45.1* 281.6 ± 62.9 267.5 ± 66.6 0.462
CK (U L)1) 60.7 ± 21.6 31.7 ± 14.5***,k,l 36.3 ± 10.2**,m,n 65.2 ± 32.8k,m 71.7 ± 27.3l,n 0.001
Amylase
(U L)1)
58.0 ± 12.8 74.1 ± 18.0** 101.6 ± 57.6* 75.2 ± 50.9 75.1 ± 21.0* 0.249
TG, triglycerides; CHOL, total cholesterol; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; VLDL-c, very-
low-density lipoprotein cholesterol; AST, aspartate aminotransferase; ALT, alanine aminotransferase; c-GT, gamma-glutamil transferase; AlP,
alkaline phosphatase; LDH, lactate dehydrogenase; CK, creatine kinase. U, 1 unit is that quantity of an enzyme which transforms 1 lmol of
substrate per minute under standardized conditions.
Values are given as mean ± SD.
Significant differences against controls (Student’s t-test, independent data): *P £ 0.05; **P £ 0.01; ***P £ 0.001.
Significant differences between mean values with common superscripts (Bonferroni test): c,d,e,f,g,i,j,mP £ 0.05; a,b,h,k,nP £ 0.01; lP £ 0.001.
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normalize during the 1-year follow-up, appear to
be linked to the impaired weight status of the
patients which was still observed after 1-year of
treatment. Mean weight and BMI on admission
were under the third percentile according to the
Spanish growth reference charts (Herna´ndez et al.,
1988), and did not reach the 10th percentile after
the 1-year period of treatment.
The low values found for RBC, haemoglobin and
MCHC on admission are in agreement with results
published by other authors in AN patients before
treatment (Palla & Litt, 1988; Devuyst et al., 1993).
Six out of the 14 patients had values below the
normal range for RBC, haematocrit and MCHC
and four of them had haemoglobin below the
normal range. All cases of anaemia found in our
group were normocytic, except one case of iron
deficiency anaemia. Iron deficiencies are infre-
quent because the amenorreic status of anorexic
patients decreases iron requirements. The increase
in the cells’ volume and in the MCH seems to be
an adaptive mechanism to the nutrient deficiency,
thus, trying to compensate for moderately reduced
RBC and haemoglobin concentrations.
No significant improvement was found in RBC
and haemoglobin with refeeding, and they re-
mained lower than in the control group at all time
points. Moreover, the correlations found between
the change in red cells and haemoglobin and the
change in anthropometrical parameters reflect that
their improvement seems to be secondary to the
nutritional status recovery and thus, dependent on
the availability of substrates for anabolic pro-
cesses. Increased metabolic demands for iron and
zinc during refeeding and nutritional recovery
have been referred previously in this group of
patients (Nova et al., 2004).
Regarding serum biochemistry, reduced glucose
and protein concentrations as well as low AST and
LDH activities compared to those of the healthy
girls reflect energy and protein sparing strategies
in response to the reduced food intakes. Glucose
and protein were recovered early once refeeding
begins, i.e. in the first month, while enzyme
activities normalized in the first 6 months.
In addition, the low AlP values might reflect a
reduction in the anabolic processes occurring
normally at this age of rapid growth, while low CK
activity could be a consequence of the probably
reduced muscle mass. A previous study has de-
scribed low serum AlP activity in AN patients that
was not due to a deficiency in zinc, the enzyme
cofactor, as plasma and hair zinc levels were
normal in these patients (Varela et al., 1992).
In the current study, five subjects in the control
group showed AlP values above the normal range.
Under these circumstances, the increase of AlP in
t1 in the AN patients indicates an improvement in
their nutritional status. In addition, the negative
correlation found between the change in AlP and
the change in weight between t0 and t1 shows that
the increase in AlP observed in t1 occurred in
those patients whose weight is less depleted on
admission and therefore gain less weight during
the first month of treatment. Similar results were
found by Heer et al. (2004) who also found a
significant increase in bone AlP with nutritional
therapy in AN patients.
Other authors have found relatively frequent
increased values of aminotransferases (Palla &
Litt, 1988; Van Binsbergen et al., 1988). This can
be due to a number of reasons such as fatty liver,
hepatic failure, dehydration or antidepressant
therapy. However, the patients in this study always
showed AST and ALT values within the normal
range. The high urea values in serum are attrib-
utable to the relatively high protein intakes that
are commonly found in these patients. In fact, in
our patients, the relative protein intake (% of total
energy) was higher than in controls in all the
stages (Nova et al., 2001). A simultaneous increase
in urea and creatinine values suggests increased
muscle catabolism, but this situation was only
found in one patient in t6, who was experiencing
acute weight loss and was severely underweight.
According to the literature and the results in this
study, hypercholesterolaemia is present in
approximately 50% of the AN patients (Mordasini
et al., 1978; Mira et al., 1987; Arden et al., 1990).
LDL-c increase is mostly determined by the severe
loss of body fat and the resulting changes in thy-
roid hormones, increased lipolysis and decreased
endogenous cholesterol synthesis accompanied by
decreased LDL removal (Weinbrenner et al.,
2004). However, although refeeding did not
decrease LDL-c, it decreased the percentage of
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patients showing high cardiovascular risk indexes
(triglycerides/HDL-c and LDL-c/HDL-c). Finally,
although high serum amylase values are typical of
patients with purging behaviour and salivary
gland enlargement, previous studies (Scheutzel &
Gerlach, 1991; Kinzl et al., 1993) have described
high serum a-amylase in approximately 20% of
restricting AN patients. A study of the changes in
salivary amylase in serum and parotid gland in
rats have shown that feeding in fasted state results
in a decrease in parotid tissue amylase activity and
a proportional increase in serum levels of parotid
isoamylase (Nagy et al., 2001).
In conclusion, this study showed that serum
biochemical parameters reflect the compromised
nutritional status of the restricting AN patients on
admission to hospital. Enzymatic activities, except
AlP, reach control values during the outpatient
period of treatment, despite total anthropometri-
cal recovery not being achieved at the end of the
follow-up. Serum AlP activity, hypercholesterola-
emia and red cells seem to need more prolonged
periods of treatment with further weight gain to
fully normalize. Therefore, these are parameters
worth monitoring during AN patients long-term
follow-up, as they might reflect good or poor re-
sponse to treatment for individual patients.
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